Mortality for Alcoholic Myocarditis in Latin America, 2000-2019.
Main Article Content
Keywords
Alcoholic cardiomyopathy, mortality, disability-adjusted life years, alcohol, heart disease
Abstract
Alcoholic myocarditis is a type of non-ischemic dilated cardiomyopathy induced by ethanol. Objectives: To determine the mortality and disease burden of alcoholic myocarditis in Costa Rica, Mexico, Colombia, Chile, Cuba and Panama from 2000 to 2019. Methods: A database was created with information from the Institute of Health Metrics based on the Global Burden of Disease (GBD), using standardised rates to determine disability-adjusted life years (DALYs), years of life with disability (YLD), incidence and mortality of alcoholic myocarditis by sex and age for the period 2000 to 2019. Results: It was shown that DALYs and YLD due to alcoholic myocarditis were found in some countries with a high trend or were maintained over time; however, the highest rates were found in Cuba. The highest rates were found in men. Conclusions: Alcoholic myocarditis is a preventable disease if excessive consumption can be stopped from an early age, the male sex was most affected, the country with the highest rates was Cuba, followed by Chile and Costa Rica, so primary prevention should be strengthened and strategies to reduce alcohol consumption implemented by the World Health Organization (WHO) should be implemented, as this has become a public health problem.
References
2. Lang RM, Badano LP, Mor-Avi V, Afilalo J, Armstrong A, Ernande L, Flachskampf FA, Foster E, Goldstein SA, Kuznetsova T, Lancellotti P, Muraru D, Picard MH, Rietzschel ER, Rudski L, Spencer KT, Tsang W, Voigt JU. Recommendations for cardiac chamber quantification by echocardiography in adults: an update from the American Society of Echocardiography and the European Association of Cardiovascular Imaging. J Am Soc Echocardiogr. 2015 Jan;28(1):1-39.e14. doi: 10.1016/j.echo.2014.10.003.
3. Bozkurt B, Colvin M, Cook J, Cooper LT, Deswal A, Fonarow GC, Francis GS, Lenihan D, Lewis EF, McNamara DM, Pahl E, Vasan RS, Ramasubbu K, Rasmusson K, Towbin JA, Yancy C; American Heart Association Committee on Heart Failure and Transplantation of the Council on Clinical Cardiology; Council on Cardiovascular Disease in the Young; Council on Cardiovascular and Stroke Nursing; Council on Epidemiology and Prevention; and Council on Quality of Care and Outcomes Research. Current Diagnostic and Treatment Strategies for Specific Dilated Cardiomyopathies: A Scientific Statement From the American Heart Association. Circulation. 2016 Dec 6;134(23):e579-e646. doi: 10.1161/CIR.0000000000000455. Epub 2016 Nov 3. Erratum in: Circulation. 2016 Dec 6;134(23):e652.
4. WHO. Las 10 principales causas de defunción. [Online].; 2020. Disponible en: https://www.who.int/es/news-room/fact-sheets/detail/the-top-10-causes-of-death.
5. WHO. Informe del grupo de trabajo OMS/ISFC sobre la definición y clasificación de las miocardiopatías. OMS. 1980; 44(6): p. 672-673.
6. Instituto Nacional de Estadística y Censos. Tasa mortalidad. [Online].; 2022. Disponible en: https://inec.cr/.
7. Instituto sobre Alcoholismo y Farmacodependencia. Encuesta Nacional Consumo de bebidas alcohólicas. [Online].; 2010. Disponible en: https://www.iafa.go.cr/wp-content/uploads/2022/07/fasciculo-2-consumo-bebidas-alcoholicas15-junio012.pdf.
8. World Heart Federation. [Online].; 2010. Disponible en: https://world-heart-federation.org/wp-content/uploads/2017/05/Cardiovascular_diseases_in_Mexico__Spanish_.pdf
9. González-Zambrano H, Amaya-Tapia G, Franco-Ramos MC. Cardiomiopatía Alcohólica en el Occidente de México. Veinticinco Años de Estudio. Sal Jal. 2018;5(3):150-154.
10. GORGAS. [Online].; Institutto Conmemorativo Gorgas de Estudios de Salud. Disponible en: http://www.gorgas.gob.pa/
11. Escobar Díaz GL, Orozco Molina AM, Núñez Montes JR, Muñoz Fabián L. Mortalidad por Enfermedades Cardiovasculares en Colombia 1993-2017. Un análisis de las políticas públicas. Salud, Barranquilla [Internet]. 2020 Dec; 36( 3 ): 558-570. Disponible en: http://www.scielo.org.co/scielo.php?script=sci_arttext&pid=S0120-55522020000300558&lng=en. Epub Oct 22, 2021. https://doi.org/10.14482/sun.36.3.616.12.
12. Ahumada DJL. Ayudándote Chile. [Online].; 2022. Disponible en: https://ayudandote.cl/2021/07/consumo-alcohol-chile/
13. Medina E, Kaempffer A. Enfermedades cardiovasculares en Chile. Aspectos epidemiológicos. Rev Chil Cardiol. 2007; 26(2): 218-220
14. PAHO. Informe sobre la situación mundial del alcohol y la salud 2018. Resumen. Washington, D.C.: Organización Panamericana de la Salud; 2019. (OPS/NMH/19-012).
15. Guzzo Merello GA. Historia Natural de la Miocardiopatía Dilatada Alcohólica. 2013. Disponible en: http://hdl.handle.net/10486/14268
16. Cederbaum AI. Alcohol metabolism. Clin Liver Dis. 2012 Nov;16(4):667-85. doi: 10.1016/j.cld.2012.08.002.
17. Vázquez-Ramírez EM, Mata-Vicente JF. Cardiomiopatía secundaria al consumo de alcohol. Med Int Méx. 2016 ene;32(1):93-102.
18. Fernández-Solà J. The Effects of Ethanol on the Heart: Alcoholic Cardiomyopathy. Nutrients. 2020; 12(2):572. https://doi.org/10.3390/nu12020572
19. Wilke A, Kaiser A, Ferency I, Maisch B. Alkohol und Myokarditis [Alcohol and myocarditis]. Herz. 1996 Aug;21(4):248-57. German. PMID: 8805005.
20. O’Keefe J, Bybee K, Lavie C, et al. Alcohol and Cardiovascular Health. J Am Coll Cardiol. 2007 Sep, 50 (11) 1009–1014. Doi: https://doi.org/10.1016/j.jacc.2007.04.089
21. Piano MR, Phillips SA. Alcoholic cardiomyopathy: pathophysiologic insights. Cardiovasc Toxicol. 2014 Dec;14(4):291-308. doi: 10.1007/s12012-014-9252-4.
22. Steiner JL, Lang CH. Etiology of alcoholic cardiomyopathy: Mitochondria, oxidative stress and apoptosis. Int J Biochem Cell Biol. 2017 Aug;89:125-135. doi: 10.1016/j.biocel.2017.06.009.
23. Jefferies JL, Towbin JA. Dilated cardiomyopathy. Lancet. 2010 Feb 27;375(9716):752-62. doi: 10.1016/S0140-6736(09)62023-7.
24. Mirijello A, Tarli C, Vassallo GA, Sestito L, Antonelli M, d'Angelo C, Ferrulli A, De Cosmo S, Gasbarrini A, Addolorato G. Alcoholic cardiomyopathy: What is known and what is not known. Eur J Intern Med. 2017 Sep;43:1-5. doi: 10.1016/j.ejim.2017.06.014.
25. Piano MR. Alcohol’s E¬ects on the Cardiovascular System. Alcohol Res. 2017;38(2):219–41. Disponible en: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5513687/.
26. Di Castelnuovo A, Costanzo S, Bagnardi V, Donati MB, Iacoviello L, de Gaetano G. Alcohol dosing and total mortality in men and women: an updated meta-analysis of 34 prospective studies. Arch Intern Med. 2006 Dec 11-25;166(22):2437-45. doi: 10.1001/archinte.166.22.2437.
27. Klatsky AL. Alcohol and cardiovascular diseases: where do we stand today? J Intern Med. 2015 Sep;278(3):238-50. doi: 10.1111/joim.12390.
28. Wilson S Colucci, Barry A Borlaug. Heart failure: Clinical manifestations and diagnosis in adults. UpToDate; 2022, Apr 20. Disponible en: https://www.uptodate.com/contents/heart-failure-clinical-manifestations-and-diagnosis-in-adults
29. Fauchier L, Babuty D, Poret P, et al. Comparison of long-term outcome of alcoholic and idiopathic dilated cardiomyopathy. Eur Heart J. 2000; 21:306-314.
30. Jens H. Henriksen SM. Complicaciones hemodinámicas cardíacas y sistémicas de la cirrosis hepática. Scandinavian cardiovascular journal. 2009 Agosto ; 43(4): p. 218-25.
31. WHO. 2022 [cited 2022 Noviembre 26 [Estrategia Mundial para Reducir el Uso Nocivo del Alcohol]. Disponible en: https://www.who.int/es/news-room/fact-sheets/detail/alcohol.
Article Sidebar
Article Details
This work is licensed under a Creative Commons Attribution-ShareAlike 4.0 International License.
RHCS uses the Creative Commons License 4.0 International (CC BY 4.0). For more information, please visit
Roger Bonilla-Carrión, Coordinación de Investigación, Universidad Hispanoamericana. San José, Costa Rica
- Escuela de Medicina y Cirugía, Universidad Hispanoamericana. San José, Costa Rica.
- Coordinación de Investigación, Universidad Hispanoamericana. San José, Costa Rica